Total Live Articles: 409

Retinal Arterial Occlusion

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Published: Mar 2021.

Retinal Arterial Occlusion

Retinal arterial occlusion, including central retinal arterial occlusion (CRAO) and branch retinal arterial occlusion (BRAO), is an ophthalmic and stroke emergency caused by obstruction of the retinal arterial circulation.

This updated UKMLA guide to retinal arterial occlusion is based on the AHA scientific statement, which covers causes, risk factors, symptoms, diagnosis, and management.

Types and Anatomy

Type Implications
Central retinal arterial occlusion (CRAO) Whole/near-whole retina affected
Branch retinal arterial occlusion (BRAO) (occlusion of a branch of the central retinal artery – distal to the central retinal artery) Only part of the retina is affected

Simplified (high-yield) blood supply to the eye:

The internal carotid artery gives off the ophthalmic artery, which then gives off the central retinal artery to supply the inner retina via multiple branch retinal arteries.

The retina has a dual blood supply:

  • The central retinal artery supplies the inner retina
  • The choroidal circulation supplies the outer retina (explains the cherry-red spot sign mentioned below)

Causes and Risk Factors

Category Description Specific causes and risk factors
Thromboembolic occlusion (non-arteritic) Most common form (~95% cases)

Blood flow is interrupted by embolism or thrombus formation

Embolisation typically arises from:

  • Ipsilateral carotid artery disease (atherosclerosis)
  • Cardiogenic source (e.g. AF, valvular heart disease, heart failure)

Risk factors:

  • Advanced age (peak incidence in >80 y/o)
  • Males
  • Cardiovascular risk factors (e.g. hypertension, dyslipidaemia, smoking, diabetes)
Inflammatory occlusion (arteritic) ~5% cases

Arteries occluded by an active inflammatory process

Most common cause: giant cell arteritis (GCA) (temporal cell arteritis)

Suggestive factors:

  • Females
  • >50 y/o
  • Jaw claudication
  • New-onset headache
  • Scalp tenderness / nodules
  • PMR
  • ↑ ESR / CRP
Rare causes
  • Cosmetic facial injections (if the material is injected into the facial arteries)
  • Hypercoagulable states
  • Paradoxical emboli and septic emboli in high-risk patients

Clinical Features

Typical presentation: sudden, painless, unilateral vision loss

CRAO BRAO
  • Monocular blindness
    • Visual acuity is often severely impaired
    • Central vision may be preserved
  • Relative afferent pupillary defect (RAPD) (Marcus Gunn pupil)
  • Typically, a visual field defect (scotoma)
  • Visual acuity is less severely impaired
  • NO relative afferent pupillary defect (RAPD) (Marcus Gunn pupil)

Retinal arterial occlusion (CRAO and BRAO) is a form of acute ischaemic stroke (specifically a retinal infarction). Therefore, 30% cases of CRAO have concurrent ischaemic stroke.

Investigation and Diagnosis

CRAO can be diagnosed if there are typical clinical features (see above) + dilated fundoscopic examination

Typical fundoscopic findings of CRAO (suggestive of retinal hypoperfusion):

  • Diffuse retinal whitening (due to inner retinal ischaemia and oedema)
  • Cherry red spot at the fovea (due to the dual retinal blood supply)
  • Retinal arterial attenuation (narrowed retinal artery – “boxcarring”)
  • Optic disc is typically normal initially

In BRAO, the classic CRAO findings are localised / segmental rather than diffuse, because only one branch of the central retinal artery is occluded. In some cases, a visible embolus might be visible.

The classic fundoscopic findings of CRAO may take time to become fully evident as the ischaemia progresses. Initially, the fundus may appear relatively normal.

Given that, a clinical history of sudden, painless vision loss combined with the presence of a relative afferent pupillary defect strongly implicates CRAO. A normal fundoscopy should NOT exclude the diagnosis.

If the fundoscopy is inconclusive, consider:

  • Optical coherence tomography (OCT) to detect retinal thickening and oedema secondary to retinal ischaemia
    • Relatively quick and effective procedure, useful in the acute setting to confirm the diagnosis
  • Fluorescein angiography to confirm delayed or absent retinal perfusion
    • Time-consuming procedure and usually not necessary to establish a definitive diagnosis

Other Investigations

Perform the following for ALL patients:

  • Visual acuity and visual field assessment
  • Structured neurological assessment to assess for stroke (e.g. NIHSS )
  • Non-contrast head CT to exclude haemorrhage

If CRAO is thought to be caused by underlying giant cell arteritis → check ESR and CRP immediately

Work up post-acute phase:

  • Carotid artery imaging (ultrasound or CT/MR)
  • Echo for structural heart disease or cardioembolic sources
  • Ambulatory cardiac rhythm monitoring for AF

CRAO vs CRVO

Key differences in CRAO vs CRVO:

Feature CRAO (central retinal arterial occlusion) CRVO (central retinal vein occlusion)
Underlying mechanism Arterial occlusion → retinal ischaemia Venous occlusion → retinal congestion and haemorrhage
Typical onset Very acute More subacute
Visual impairment Usually severe and profound monocular blindness Variable visual loss (may be mild to severe)
RAPD Common May occur
Fundoscopic findings Diffuse pale / white retina + cherry-red spot Blood-shot retina: widespread retinal haemorrhages and oedema

Management

Acute Management

CRAO is a medical emergency equivalent to an acute ischemic stroke.

Definitive management: acute reperfusion therapies (for non-arteritic / thromboembolic CRAO):

  • 1st line: consider IV thrombolysis (e.g. alteplase) if the patient presented <4.5 hours of symptom onset with NO contraindications
  • If IV thrombolysis is contraindicated and the patient has visual deficits → consider intra-arterial thrombolysis (it remains an unproven therapy with procedural risks like arterial dissection, requires a specialised endovascular team)

Hyperbaric oxygen therapy can be used as a safe temporary measure to salvage retinal tissue and preserve viability while definitive reperfusion therapy is pursued (the retina can derive up to 97% of its oxygen from the underlying choroidal circulation under hyperbaric conditions).

Traditional “conservative” therapies aiming to lower IOP or dilating vessels to dislodge the embolus are no longer endorsed, including:

  • Ocular massage
  • Anterior chamber paracentesis
  • Topical pressure-lowering drugs
  • Haemodilution

Current evidence shows these are not effective (yielding worse visual recovery rates than the natural history of the disease), and some may even be harmful.

If CRAO secondary to giant cell arteritis is suspected, give high-dose IV methylprednisolone to preserve vision in the contralateral eye, followed by a temporal artery biopsy.

Chronic Management (Secondary Prevention)

If CRAO is caused by atherosclerosis of unknown origin:

  • Long-term antiplatelet therapy (aspirin or clopidogrel)
  • If an underlying cardioembolic source (e.g. AF) is found → long-term oral anticoagulation

Interventions:

  • If severe, high-grade stenosis of the ipsilateral carotid artery is found → surgical revascularisation (carotid endarterectomy or stenting) is indicated to prevent recurrent strokes

References

Related Articles

Ischaemic Stroke

Giant Cell Arteritis (GCA)

Atrial Fibrillation (AF)

Heart Valve Disease

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.